• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • Guidelines for the Information Submission of Cosmetics Registration and Filing (Trial Version)

Guidelines for the Information Submission of Cosmetics Registration and Filing (Trial Version)

Friday, 28 May 2021 / Published in Cosmetics, News, NMPA Registration in China

Guidelines for the Information Submission of Cosmetics Registration and Filing (Trial Version)

In accordance with the CSAR (Cosmetics Supervision and Administration Regulation), the NMPA (National Medical Products Administration) released the Technical Guidelines for the Submission of Information for Cosmetics Registration and Filing (Trial Version) on April 25, 2021.

Highlights

  • The regulatory draft applies to the registration and filing process of both cosmetics and new ingredients, e.g., user account activation and data submission.
  • Once the Domestic Responsible Agent (DRA) has obtained the digital certificate (Certificate Authority, CA), the submission of the paper version can be replaced by the digital version to the NMPA. The changes before and after the implementation of this trial version is listed below:
    • Before the implementation
      • The digital certificate (Certificate Authority, CA) didn’t exist.
      • The NMPA accepts the original hard copy of the required documents (registrant/filer application form, adverse reaction monitoring overview form, quality management system overview form, etc.) that must be signed and stamped for submission.
    • After the implementation
      • The digital certificate (Certificate Authority, CA) was introduced in the technical guidelines for this trial version.
      • The NMPA accepts the original hard copy or electronic version of the required documents (registrant/filer application form, adverse reaction monitoring overview form, quality management system overview form, etc.) that still must be signed and stamped for submission. However, the DRA needs to obtain the CA to meet the precondition for submitting the electronic version.

By James Xu. Contact Cisema if you would like to learn more.

Tagged under: cosmetics, cosmetics filing, cosmetics registration

What you can read next

cosmetic ingredient safety information
China’s cosmetic ingredient safety information requirements have been updated
Cosmoprof worldwide bologna 2022
Cosmoprof Worldwide Bologna 2022 – Meet with Cisema
China food production licensing rules
China food production licensing rules update with effect from November 2022

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Clinical trials of sodium hyaluronate complex solution

    Clinical trials of sodium hyaluronate complex solution – draft guidelines issued

    Clinical trials of sodium hyaluronate complex s...
  • China registration of ophthalmic optical measurement devices

    China registration of ophthalmic optical measurement devices – Technical review guidelines issued

    China registration of ophthalmic optical measur...
  • Pre-communication for Hainan medical device clinical RWD

    Pre-communication for Hainan medical device clinical RWD application – Trial measures implemented

    Pre-communication for Hainan medical device cli...
  • Registration platform for cosmetic raw materials safety information

    Registration platform for cosmetic raw materials safety information – Draft guidelines issued

    The registration platform for cosmetic raw mate...
  • Technical guidelines for reporting cosmetics formulas

    Technical guidelines for reporting cosmetics formulas – draft issued

    Technical guidelines for reporting cosmetics fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP